Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction.

  • Volker Rudolph
  • Britta Goldmann
  • Constantin Boes
  • Tanja Katharina Rudolph
  • Anna Klinke
  • Kai Friedrichs
  • Denise Lau
  • Karl Wegscheider
  • Munif Haddad
  • Thomas Meinertz
  • Stephan Baldus

Abstract

Besides its well-established role in atherosclerosis, myeloperoxidase (MPO) has gained attention as a prognostic indicator in cardiovascular disease. Previous studies assessed MPO retrospectively and at a single time point. The current study aimed to evaluate the prognostic information of MPO prospectively and in consecutive measurements in patients presenting with chest pain.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer3
ISSN0167-5273
StatusVeröffentlicht - 2011
pubmed 20846733